Japan briefs: Daiichi Sankyo launches silodosin in China; Fujifilm Diosynth UK unit commissioned
22 April 2013
Daiichi Sankyo admits supply problem with flu vaccine; gains approval for silodosin in China
23 September 2011
Showing 1-2 of 2 articles
- 1
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Italy's pharma market slump set to continue, warns GlobalData
